QVT Financial LP, a New York-based hedge fund sponsor, invests globally in public equity, debt, and alternative markets. The firm employs diverse strategies, including convertible arbitrage, investment grade and capital structure arbitrage, and closed-end fund arbitrage. QVT focuses on structured finance, private placements, high yield, and distressed debt investments.
Notable portfolio companies include Kriya Therapeutics, Regenxbio, and Roivant Sciences. QVT's team comprises original thinkers with non-traditional backgrounds, bringing unique expertise to their investments. The firm's core investment areas include biotech/healthcare (Ophiucus), technology (Telescopium), and energy/shipping (Argo), reflecting their commitment to diverse and innovative investment opportunities.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.